Anti-LPIN2 monoclonal antibody

Pre-made anti-LPIN2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LPIN2/LPIN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2579-Ab-1/ GM-Tg-hg-IP2579-Ab-2Anti-Human LPIN2 monoclonal antibodyHuman
GM-Tg-rg-IP2579-Ab-1/ GM-Tg-rg-IP2579-Ab-2Anti-Rat LPIN2 monoclonal antibodyRat
GM-Tg-mg-IP2579-Ab-1/ GM-Tg-mg-IP2579-Ab-2Anti-Mouse LPIN2 monoclonal antibodyMouse
GM-Tg-cynog-IP2579-Ab-1/ GM-Tg-cynog-IP2579-Ab-2Anti-Cynomolgus/ Rhesus macaque LPIN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2579-Ab-1/ GM-Tg-felg-IP2579-Ab-2Anti-Feline LPIN2 monoclonal antibodyFeline
GM-Tg-cang-IP2579-Ab-1/ GM-Tg-cang-IP2579-Ab-2Anti-Canine LPIN2 monoclonal antibodyCanine
GM-Tg-bovg-IP2579-Ab-1/ GM-Tg-bovg-IP2579-Ab-2Anti-Bovine LPIN2 monoclonal antibodyBovine
GM-Tg-equg-IP2579-Ab-1/ GM-Tg-equg-IP2579-Ab-2Anti-Equine LPIN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2579-Ab-1/ GM-Tg-hg-IP2579-Ab-2; GM-Tg-rg-IP2579-Ab-1/ GM-Tg-rg-IP2579-Ab-2;
GM-Tg-mg-IP2579-Ab-1/ GM-Tg-mg-IP2579-Ab-2; GM-Tg-cynog-IP2579-Ab-1/ GM-Tg-cynog-IP2579-Ab-2;
GM-Tg-felg-IP2579-Ab-1/ GM-Tg-felg-IP2579-Ab-2; GM-Tg-cang-IP2579-Ab-1/ GM-Tg-cang-IP2579-Ab-2;
GM-Tg-bovg-IP2579-Ab-1/ GM-Tg-bovg-IP2579-Ab-2; GM-Tg-equg-IP2579-Ab-1/ GM-Tg-equg-IP2579-Ab-2
Products NameAnti-LPIN2 monoclonal antibody
Formatmab
Target NameLPIN2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LPIN2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2579-Ag-1Recombinant multi-species LPIN2 protein
    ORF Viral VectorvGMLP001786human LPIN2 Lentivirus particle
    ORF Viral VectorpGMLP001786human LPIN2 Lentivirus plasmid


    Target information

    Target IDGM-IP2579
    Target NameLPIN2
    Gene ID9663,64898,316737,695641,607640,101087178,514448,100051300
    Gene Symbol and Synonyms2610511G02Rik,LPIN2
    Uniprot AccessionQ92539
    Uniprot Entry NameLPIN2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101577
    Target ClassificationN/A

    The target: LPIN2, gene name: LPIN2, also named as . Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.